crispr based diagnostics market, crispr based diagnostics market insights, crispr based diagnostics market share, crispr based diagnostics market forecast, crispr based diagnostics market growth, crispr based diagnostics industry
How large is the crispr-based diagnostics market, and what is its growth trajectory?
The CRISPR-based diagnostics market size has grown rapidly in recent years. It will grow from $4.35 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to the rise in healthcare expenditure, the rise in demand for gene editing, the rise in prevalence and incidence of chronic diseases, the growth in awareness of treatments, and the increase in the prevalence of genetic diseases.
The CRISPR-based diagnostics market size is expected to see rapid growth in the next few years. It will grow to $9.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to rising demand for rapid and accurate diagnostics, growing applications in infectious disease detection, government and institutional funding, improved detection of antibiotic resistance, and growing awareness and acceptance of CRISPR technologies. Major trends in the forecast period include point-of-care (POC) testing, CRISPR-Cas12 and Cas13 systems, personalized medicine and genetic screening, integration with nanotechnology and biosensors, and CRISPR-based early disease detection.
Get Your Free Sample of The Global CRISPR-Based Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp
What are the key forces behind the crispr-based diagnostics market’s growth in recent years?
The rising incidence of infectious diseases is expected to propel the growth of the CRISPR-based diagnostics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly from person to person, through contaminated surfaces, food, water, or vectors like insects. The incidence of infectious diseases is rising due to factors such as globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and insufficient healthcare access. CRISPR-based diagnostics enhance the fight against infectious diseases by delivering rapid and accurate pathogen detection, facilitating early diagnosis, timely intervention, and effective containment measures. For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the rising incidence of infectious diseases is driving the CRISPR-based diagnostics market.
What are the major segments of the crispr-based diagnostics market?
The CRISPR-based diagnostics market covered in this report is segmented –
1) By Product: Kits, Buffer Solutions, Software, Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Other Techniques
3) By Disease: Infectious Diseases, Non-Infectious Diseases
4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits
2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers
3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software
4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report
Which companies dominate the crispr-based diagnostics market?
Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.
What major trends will shape the crispr-based diagnostics market during the forecast period?
Major companies operating in the CRISPR-based diagnostics market are focusing on developing strategic partnerships to enhance accessibility to rapid and accurate diagnostics through CRISPR-based point-of-care tests. A strategic partnership is a long-term collaboration between two or more organizations that share resources and expertise to achieve mutual goals and enhance their competitive advantage. For instance, in August 2023, CrisprBits Private Limited, an India-based biotechnology company, announced a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics company, to develop CRISPR-based Point-of-Care Tests (POCTs). This collaboration focuses on creating rapid, precise, and cost-effective diagnostic tools leveraging CRISPR technology for detecting pathogens and genetic markers. These POCTs aim to enhance diagnostic accessibility in diverse settings, including resource-limited areas, while ensuring swift and accurate disease detection. The partnership combines CrisprBits’ expertise in CRISPR-based platforms with Molbio’s manufacturing and distribution capabilities to bring these tests to a global market.
What are the key regional dynamics of the crispr-based diagnostics market, and which region leads in market share?
North America was the largest region in the CRISPR-based diagnostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The CRISPR-Based Diagnostics Market Report 2025 Offer?
The crispr-based diagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
CRISPR (clustered regularly interspaced short palindromic repeats)-based diagnostics refers to advanced molecular tools leveraging the CRISPR-Cas system to detect specific nucleic acid sequences with high precision and speed for identifying diseases or genetic markers, offering revolutionary capabilities in medical and genomic analysis. These diagnostics are utilized in applications such as detecting infectious diseases, identifying genetic disorders, and monitoring mutations in cancer research and treatment, with growing potential in personalized medicine and point-of-care testing.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
